SCHEMBL7137696

SCHEMBL7137696

CCN(CC(=O)O)C(C)C#N

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.34
ADRA2A P08913 1/20 0.34
ADRA2B P18089 1/20 0.34
HTR2A P28223 1/20 0.34
HRH1 P35367 1/20 0.34
KCNH2 Q12809 1/20 0.34
DPP4 P27487 1/20 0.33
FDPS P14324 1/20 0.30
EYA2 O00167 1/20 0.30
APP P05067 1/20 0.30
ACE P12821 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM5 P08912 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19226113 0.84 CHRM2 (0.33) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL298413 0.78
SCHEMBL868741 0.76 ADRA2A (0.39) PGRADRA2AADRA2BHTR2AHRH1
Hydrochloric Acid SCHEMBL10492850 0.75 TSHR (0.35)
SCHEMBL2561091 0.75 DPP4 (0.39) ADRA2ADPP4EYA2APPACE
SCHEMBL3246687 0.74 KMT2A (0.44) TDP1
SCHEMBL593204 0.74 ADRA2A (0.38) PGRADRA2AADRA2BHTR2AHRH1
Hydrochloric Acid SCHEMBL3235384 0.73 KMT2A (0.43) TDP1
SCHEMBL593136 0.72 ADRA2A (0.37) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL4629162 0.72 GABRP (0.38) PGRADRA2AADRA2BHTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506761-B1 Compound of the invention are active as inhibitors of Thrombin and are useful in treating disease states in mammals which are characterized by abnormal thrombosis and have the following structure: CORVAS INTERNATIONAL, INC. 2003-01-14 US disclosed
US-6506760-B1 Compounds of the invention are active as inhibitors of Thrombin and are useful in treating disease states in mammals which are characterized by abnormal thrombosis and have the following structure: CORVAS INTERNATIONAL, INC. 2003-01-14 US disclosed
WO-2001079193-A2 SUBSTITUTED HYDRAZINYL HETEROAROMATIC INHIBITORS OF THROMBIN CORVAS INTERNATIONAL, INC. (US) 2001-10-25 WO disclosed